Introduction to Embolic Protection Devices
Embolic protection devices are used to minimize the release of fragments in the bloodstream and prevention of blockages in the blood vessels during percutaneous cardiac procedures. Additionally, these devices tend to reduce complication rates during carotid and saphenous vein graft procedures. These devices are mainly used in case of neurovascular, peripheral vascular and cardio vascular disorders. There are a variety of such systems available depending upon the end user and the application. The recent technical developments in these devices have made it possible to use them for numerous applications. One of their main use is to remove plague and debris at time of trans-catheter aortic valve replacement, owing to which the recent expansion in the industry is anticipated to support the market growth for global embolic protection devices market.
Market Size and Forecast
The global embolic protection devices market is anticipated to record a CAGR of around 9% over the forecast period, i.e., 2019-2027 on account of increasing neurovascular, cardiovascular and peripheral disease cases. The rising geriatric population along with the property of these devices to protect the brain in case of embolization by minimizing the risk of stroke and cerebral damage are the major factors anticipated to drive the market growth. The increasing government investments in healthcare sector and rising consumer awareness that result in a growing prevalence of minimally invasive treatments are further estimated to support the market growth.
The market is segmented by product, by application and by end user. The product segment is further segmented into distal occlusion filters, proximal occlusion filters and distal filters out of which, the distal occlusion filters segment is anticipated to have highest CAGR during the forecast period on the back of benefits offered by the product, for instance, prevention of embolization via balloon occlusion, low crossing profile and others. The distal filter segment is anticipated to witness a strong CAGR as well, owing to broad variety of specifications, filter details, crossing profile, landing zone length and pore size. Their easy to deploy nature, no interference with lesion visualization and maintenance of ante-grade blood flow are expected to drive the market growth. CLICK TO DOWNLOAD SAMPLE REPORT
The application segment is further sub-segmented into neurovascular, cardio vascular and peripheral vascular, out of which, the cardiovascular segment is predicted to hold leading shares on account of rising geriatric population and increasing cases of cardio vascular diseases owing to unhealthy lifestyle and improper eating habits. The use of embolic protection helps in reduction of complications owing to debris release in blood stream and small vessels. The peripheral vascular segment is anticipated to witness significant growth on the back of increasing blood disorders and related problems. According to Centers for Disease Control and Prevention, in United States about 8.5 million people have peripheral vascular disease out of which 20% people are above 60 and with approximately only 25% people have prior knowledge. The end user segment is further segmented into hospitals, ambulatory surgical centers and others, out of which, the hospitals segment is estimated to have leading shares on the back of increasing angioplasty procedures coupled with rise in government initiatives to provide better health care facilities and improved reimbursement policies.
Growth Drivers
Growing Rate of Cardiac Diseases
It is estimated that around 17.9 million people die annually due to heart cardio vascular disease which accounts for around 31% of the death globally as stated by the World Health Organization. Out of these, more than 75% occur in low and middle income countries with 85% of the cases occurring as a result of heart attack and strokes. The embolic protection devices help in providing effective heart and brain treatments with reduced pain and trauma. Additionally, the expansion in global trans-catheter aortic valve replacement system market is estimated to drive the embolic protection devices market growth.
Restraints
The high costs associated with the use of embolic protection system is anticipated to hinder the market growth as it is unaffordable for people living in certain low income countries. Additionally, product failures coupled with presence of better alternatives in the market are expected to restrict the product demand.
Market Segmentation
Our-in depth analysis of the embolic protection devices market includes the following segments:
By Product
- Distal Occlusion Filters
- Proximal Occlusion Filters
- Distal Filters
By Application
- Neuro Vascular
- Peripheral Vascular
- Cardio Vascular
By End User
- Hospitals
- Ambulatory Surgical Centers
- Others
By Region
On the basis of regional analysis, the global embolic protection devices market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region.
The market in North America is anticipated to hold the leading market share on the back of rise in demand for minimal invasive products, technological advancements and presence of key market players. The government initiatives and investments in the healthcare sector coupled with increase in cardiovascular disease cases owing to increasing geriatric population and changing lifestyle of the people are expected to drive the market growth in the region. The market in Europe is expected to hold second largest market share owing to huge healthcare expenditure capability, availability of better healthcare facilities and growing healthcare infrastructure. The increasing cases of cardio vascular diseases in the region are estimated to boost the market growth. Moreover, the market in Asia-Pacific is expected to witness highest growth on the account of increasing healthcare awareness, rising population especially in China and India, availability of better healthcare facilities and improvements in standard of living.
The global embolic protection devices market is further classified on the basis of region as follows:
- North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis
- Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Opportunity Analysis
- Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC, Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis
- Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Opportunity Analysis.
- Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth & Opportunity Analysis
Top Featured Companies Dominating the Market
- Abbott Laboratories
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Boston Scientific Corp
- Transverse Medical, Inc
- Medtronic Plc
- Edward Lifesciences
- Innovative Cardiovascular Solutions
- Claret Medical, Inc.
- Gore Medical
